BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30566384)

  • 1. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019; 35(1):1-2. PubMed ID: 30566384
    [No Abstract]   [Full Text] [Related]  

  • 2. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
    [No Abstract]   [Full Text] [Related]  

  • 3. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):77-78. PubMed ID: 30676206
    [No Abstract]   [Full Text] [Related]  

  • 4. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):259-260. PubMed ID: 38597927
    [No Abstract]   [Full Text] [Related]  

  • 5. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):603-604. PubMed ID: 30362869
    [No Abstract]   [Full Text] [Related]  

  • 6. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2018 Dec; 34(10):657-658. PubMed ID: 30376398
    [No Abstract]   [Full Text] [Related]  

  • 7. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):523-524. PubMed ID: 31644360
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular drug delivery-eye on innovation.
    Rupenthal ID; O'Rourke M
    Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
    [No Abstract]   [Full Text] [Related]  

  • 9. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Nov; 35(9):467-468. PubMed ID: 31682182
    [No Abstract]   [Full Text] [Related]  

  • 10. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):137. PubMed ID: 30785810
    [No Abstract]   [Full Text] [Related]  

  • 11. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Jun; 35(5):263-264. PubMed ID: 30994391
    [No Abstract]   [Full Text] [Related]  

  • 12. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 May; 35(4):201-202. PubMed ID: 30896288
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of pathological conditions on drug penetration into the anterior segment.
    Foulks GN
    Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
    [No Abstract]   [Full Text] [Related]  

  • 14. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 May; 30(4):301-2. PubMed ID: 24807022
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of the anterior segment.
    Int Ophthalmol Clin; 1980; 20(3):1-194. PubMed ID: 7419370
    [No Abstract]   [Full Text] [Related]  

  • 16. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):509-10. PubMed ID: 26468598
    [No Abstract]   [Full Text] [Related]  

  • 17. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 May; 29(4):379. PubMed ID: 23627907
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular drugs and drug delivery systems - Current trends and future perspectives.
    Rupenthal ID; Daugherty AL
    Drug Discov Today; 2019 Aug; 24(8):1425-1426. PubMed ID: 31330186
    [No Abstract]   [Full Text] [Related]  

  • 19. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
    [No Abstract]   [Full Text] [Related]  

  • 20. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2016 Apr; 32(3):133-4. PubMed ID: 27035408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.